Unternehmensübersicht
HealthEquity, Inc. operates within the healthcare sector, specifically serving the health information services industry by delivering technology-enabled service platforms to consumers and employers across the United States. These platforms include health savings accounts, a dedicated investment platform, and online-only automated investment advisory services facilitated by Advisor, a web-based tool that provides flexible spending solutions. The company demonstrates significant scale with a market capitalization of $7.05 billion and total annual revenue of $1.31 billion, supported by an operational workforce of 2,814 employees. These financial figures indicate that HealthEquity, Inc. has established itself as a substantial entity within the health information services landscape, commanding a valuation that reflects investor confidence in its recurring revenue model and technological infrastructure.
Finanzielle Gesundheit
The company reported a trailing twelve-month revenue of $1.31 billion, generating net income of $215.20 million and EBITDA of $482.14 million, which reveals a cost structure where operating expenses and taxes consume a significant portion of top-line growth before reaching the bottom line. The business maintains robust financial flexibility with free cash flow of $338.05 million, a metric that underscores its ability to fund operations and investments without relying heavily on external financing. Profitability analysis shows a gross margin of 69.5%, indicating high efficiency in cost of goods sold relative to sales, while an operating margin of 21.6% demonstrates effective management of operating expenses, culminating in a profit margin of 16.4%. Regarding capital structure, the company holds $318.93 million in cash against $1.00 billion in total debt, resulting in a debt-to-equity ratio of 47.53% that suggests a moderately leveraged balance sheet rather than a highly conservative or risky one. Liquidity is strong, evidenced by a current ratio of 3.27, which signifies that the firm holds more than three times the assets required to cover its short-term liabilities. Management effectiveness is further highlighted by a return on equity of 10.2% and a return on assets of 6.0%, metrics that indicate the company generates solid returns on the capital provided by shareholders and the total asset base.
Bewertungsanalyse
Valuation metrics present a mixed picture, with a trailing P/E ratio of 33.54 compared to a forward P/E of 15.46, implying that the market expects a significant acceleration in earnings growth to justify the current multiple. The price-to-book ratio stands at 3.33, suggesting that the stock trades at a substantial premium over its book value, reflecting market expectations of future growth and intangible asset value not captured on the balance sheet. Alternative valuation measures include a price-to-sales ratio of 5.37 and an EV/EBITDA of 15.87, which provide context for the company's valuation relative to its sales volume and earnings power before interest, taxes, depreciation, and amortization. Historical price volatility is captured by the 52-week high of $116.65 and the 52-week low of $72.76, indicating a trading range where the current market price has experienced considerable fluctuation over the past year. The beta of 0.32 reveals that the stock exhibits low price volatility relative to the broader market, behaving as a defensive investment that moves with significantly less intensity than the overall equity market index.
Growth & Income
Growth dynamics are characterized by a revenue growth rate of 7.3% year-over-year and an earnings growth rate of 92.4% year-over-year, indicating that profitability is expanding at a pace far exceeding top-line sales growth, likely driven by operational leverage and margin expansion. As a non-dividend payer, HealthEquity, Inc. has a dividend yield of N/A and a payout ratio of 0.0%, which means the company retains all earnings to reinvest into business expansion, technology development, or debt reduction rather than distributing cash to shareholders. This reinvestment strategy aligns with the high earnings growth trajectory, prioritizing capital allocation for future value creation over immediate income distribution. The overall growth and income profile suggests a capital-intensive reinvestment model typical of high-growth technology firms in the healthcare sector, where value is generated through expansion rather than dividend yields.